source
- Researchers Highlight Tau and Blood‑Brain Barrier Advances at Alzheimer’s ConferenceSTAT’s AAIC in 30 newsletter reported that tau protein remains the central focus of Alzheimer’s research presented at the recent conference in London. Scientists discussed new strategies aimed at d…
- Roche stops two Huntington's disease gene-silencing programs after disappointing trial dataRoche announced it is ending development of two gene‑silencing candidates aimed at Huntington's disease after data failed to meet expectations. The decision follows a recent readout that showed in…